ZANUBRUTINIB Pharmacologic Class Indexing

Class set ID
2aa420ab-c770-46f8-877d-cb415c75856b
Version
2
Effective date
20210823
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use BRUKINSA safely and effectively. See full prescribing information for BRUKINSA. BRUKINSA ® (zanubrutinib) capsules, for oral use BRUKINSA ® (zanubrutinib) tablets, for oral use Initial U.S. Approval: 2019BeOne Medicines USA, Inc. | AndersonBrecon Inc. | Changzhou SynTheAll Pharmaceutical Co., Ltd | Catalent CTS, LLC | BeOne Pharmaceutical (Suzhou) Co.,Ltd | Catalent Pharma Solutions, LLC | Allpack Group AG | Siegfried Evionnaz SA | Sharp Packaging Services, LLC2026020222